ORGO vs WELL · rev $81.0M vs P/E 100, rev $10.84B
Organogenesis Holdings Inc (ORGO) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
Organogenesis Holdings Inc (ORGO) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
Latest reported ORGO revenue for 2026-06-30 was $81.0M. Net income was -$149.4M. ORGO currently screens at market cap $301.1M.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
ORGO currently screens at market cap $301.1M. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the ORGO and WELL stock pages for the full models.
Not investment advice.